Novo Nordisk A/S
Insulin containing pharmaceutical compositions

Last updated:

Abstract:

The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Status:
Grant
Type:

Utility

Filling date:

20 Feb 2019

Issue date:

24 Mar 2020